Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.5M Buy
544,227
+503,436
+1,234% +$44.4M 0.01% 706
2025
Q4
$2.66M Sell
40,791
-5,536
-12% -$442K ﹤0.01% 1848
2025
Q3
$3.8M Sell
46,327
-1,828
-4% -$132K ﹤0.01% 1651
2025
Q2
$3.17M Sell
48,155
-3,140
-6% -$195K ﹤0.01% 1700
2025
Q1
$3.36M Buy
51,295
+45
+0.1% +$3.05K ﹤0.01% 1629
2024
Q4
$3.93M Sell
51,250
-6,181
-11% -$534K ﹤0.01% 1599
2024
Q3
$4.8M Buy
57,431
+1,620
+3% +$108K ﹤0.01% 1531
2024
Q2
$3.08M Buy
55,811
+16,231
+41% +$882K ﹤0.01% 1720
2024
Q1
$2.75M Buy
39,580
+2,580
+7% +$164K ﹤0.01% 1743
2023
Q4
$2.05M Buy
37,000
+790
+2% +$35.6K ﹤0.01% 1921
2023
Q3
$1.3M Hold
36,210
﹤0.01% 2106
2023
Q2
$1.14M Buy
36,210
+9,510
+36% +$364K ﹤0.01% 2212
2023
Q1
$823K Hold
26,700
﹤0.01% 2320
2022
Q4
$827K Buy
26,700
+5,200
+24% +$119K ﹤0.01% 2375
2022
Q3
$404K Buy
+21,500
New +$411K ﹤0.01% 2742

Other funds holding ACLX

AllianceBernstein's ACLX Position: Q1 2026 in Review

AllianceBernstein increased its Arcellx (ACLX) stake by 1,234% in Q1 2026, buying an estimated $44.4M and bringing the position to 544,227 shares worth $35.5M. The position accounts for 0.01% of the portfolio, ranked #706.

AllianceBernstein first reported a position in ACLX in Q3 2022 and has held it in 15 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • AllianceBernstein held 544,227 shares of Arcellx worth $35.5M as of Q1 2026.
  • AllianceBernstein bought 503,436 Arcellx shares in Q1 2026, an estimated $44.4M.
  • Arcellx made up 0.01% of AllianceBernstein's portfolio in Q1 2026, its #706 holding.
  • AllianceBernstein first reported a position in Arcellx in Q3 2022 and has held it in 15 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.